The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants
Post-osseointegration Biological Failure of Dental Implant, Alveolar Bone Loss
About this trial
This is an interventional screening trial for Post-osseointegration Biological Failure of Dental Implant focused on measuring mucosal tissue thickness, dental implant, marginal bone loss, soft tissue
Eligibility Criteria
Inclusion Criteria:
- >18 years of age
- no medical contraindication for implant surgery
- missing teeth in the posterior mandibular area requiring two implants supported three unit bridge prosthetic restoration
- fully healed bone sites (at least 3 months after extraction)
- minimum of 6mm bone width and 10 mm bone height above inferior alveolar canal
- healthy soft tissue
- minimum 2mm keratinized gingiva
- no bone augmentation procedures before and during implant placement.
Exclusion Criteria:
The patients will be excluded if they will not meet inclusion criteria and additionally have
- poor oral hygiene
- uncontrolled periodontitis
- smoking
Sites / Locations
- Cukurova University Faculty of DentistryRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Thick mucosal tissue
Thin mucosal tissue
Thickened mucosa with connective tissue
Thickened mucosa with ADM
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted.
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted.
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted. Soft tissue augmentation will be performed with sub epithelial connective tissue graft.
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted. Acellular dermal matrix, thick 1 x 4 cm will be used for vertical soft tissue augmentation.